NCT07039812 The Effect of Virtual Reality and Eye Mask During Dressing After CABG Surgery
| NCT ID | NCT07039812 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | CABG |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-02-24 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-02-24 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effects of virtual reality (VR) and eye mask (EM) applications on pain, anxiety, and physiological parameters during dressing after Coronary Artery Bypass Graft (CABG) surgery. Postoperative dressing procedures, especially after sternotomy, often cause significant pain and anxiety in patients. These issues can negatively impact recovery and increase the need for medication. Non-pharmacological interventions such as VR and EM may help reduce these symptoms. In this randomized controlled trial, 90 patients are divided into three groups: VR group, EM group, and a control group receiving standard care. Pain and anxiety levels are monitored baseline, immediately after, and 15 minutes after both the first and second dressing procedures. Physiological parameters are measured baseline, during, immediately after, and 15 minutes after both dressing procedures. Additionally, analgesic use is followed baseline and immediately after each dressing procedure. The study is conducted in a cardiovascular intensive care unit in Istanbul, Türkiye. It is expected that the findings will support the integration of VR and EM as effective, low-cost, and non-invasive options for postoperative care, improving patient comfort and healthcare quality.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18-65 years * First-time coronary artery bypass graft (CABG) surgery for coronary artery disease * ASA physical status I, II, or III * Conscious, oriented, and cooperative * Able to communicate verbally * Provided written informed consent Exclusion Criteria: * Presence of sternal wound infection or inflammation * Intubated at the time of assessment * Undergoing revision surgery * Receiving anesthesia or sedation in the ICU * Experiencing intraoperative or postoperative complications * Inability to speak Turkish * Hearing or visual impairment * Diagnosed psychiatric or cognitive disorder * Diagnosis of epilepsy * Body mass index (BMI) ≥ 30 * Participation in another clinical trial during the same period
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07039812 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying CABG. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07039812 currently recruiting?
Yes, NCT07039812 is actively recruiting participants. Contact the research team at tugce.bozkurt10@ogr.iuc.edu.tr for enrollment information.
Where is the NCT07039812 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07039812 clinical trial?
NCT07039812 is sponsored by Istanbul University - Cerrahpasa. The trial plans to enroll 90 participants.